Cargando…
A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization
STUDY QUESTION: Is the ongoing pregnancy rate with a new aqueous formulation of subcutaneous progesterone (Prolutex(®)) non-inferior to vaginal progesterone (Endometrin(®)) when used for luteal phase support of in vitro fertilization? SUMMARY ANSWER: In the per-protocol (PP) population, the ongoing...
Autores principales: | Baker, Valerie L., Jones, Christopher A., Doody, Kevin, Foulk, Russell, Yee, Bill, Adamson, G. David, Cometti, Barbara, DeVane, Gary, Hubert, Gary, Trevisan, Silvia, Hoehler, Fred, Jones, Clarence, Soules, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164149/ https://www.ncbi.nlm.nih.gov/pubmed/25100106 http://dx.doi.org/10.1093/humrep/deu194 |
Ejemplares similares
-
Patients’ administration preferences: progesterone vaginal insert (Endometrin®) compared to intramuscular progesterone for Luteal phase support
por: Beltsos, Angeline N, et al.
Publicado: (2014) -
Subcutaneous progesterone versus vaginal progesterone for luteal-phase support in frozen-thawed embryo transfer: A cross-sectional study
por: Aflatoonian, Abbas, et al.
Publicado: (2021) -
Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials
por: Doblinger, Jakob, et al.
Publicado: (2016) -
Subcutaneous progesterone versus vaginal progesterone for luteal phase support in in vitro fertilization: A retrospective analysis from daily clinical practice
por: Schütt, Marcel, et al.
Publicado: (2021) -
Luteal Phase Support Using Subcutaneous Progesterone: A Systematic Review
por: Conforti, Alessandro, et al.
Publicado: (2021)